Bedford, Canada

Mark Filiaggi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dalhousie University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Filiaggi. Retrieved from https://idiyas.com/inventor/mark-filiaggi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark Filiaggi: Innovator in Polyphosphate Glass Microspheres

Introduction

Mark Filiaggi is a notable inventor based in Bedford, CA. He has made significant contributions to the field of medical and dental treatments through his innovative work with polyphosphate glass microspheres. His research and inventions have the potential to enhance therapeutic applications in various medical procedures.

Latest Patents

Mark Filiaggi holds a patent for "Polyphosphate glass microspheres, methods of making and uses thereof." This invention involves the preparation of polyphosphate glass microspheres (PGMs) using a polyphosphate coacervate. These microspheres can be loaded with various therapeutic agents, making them useful for a range of medical and dental procedures and treatments. He has 1 patent to his name.

Career Highlights

Mark Filiaggi is affiliated with Dalhousie University, where he continues to engage in research and development in his field. His work is characterized by a commitment to advancing medical technologies and improving patient outcomes.

Collaborations

Mark has collaborated with several professionals in his field, including Arash Momeni. These collaborations have contributed to the development and refinement of his innovative ideas.

Conclusion

Mark Filiaggi's work with polyphosphate glass microspheres represents a significant advancement in medical technology. His contributions are poised to impact various therapeutic applications positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…